Ad is loading...
BIO
Price
$323.69
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
83 days until earnings call
NVST
Price
$20.37
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
76 days until earnings call
Ad is loading...

BIO vs NVST

Header iconBIO vs NVST Comparison
Open Charts BIO vs NVSTBanner chart's image
Bio-Rad Laboratories
Price$323.69
Change-$0.00 (-0.00%)
Volume$276.63K
CapitalizationN/A
Envista Holdings
Price$20.37
Change-$0.00 (-0.00%)
Volume$878.77K
CapitalizationN/A
BIO vs NVST Comparison Chart
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BIO vs. NVST commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and NVST is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BIO: $325.58 vs. NVST: $21.39)
Brand notoriety: BIO and NVST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 50% vs. NVST: 95%
Market capitalization -- BIO: $9.79B vs. NVST: $3.67B
BIO [@Medical Specialties] is valued at $9.79B. NVST’s [@Medical Specialties] market capitalization is $3.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, NVST is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 5 TA indicator(s) are bullish while NVST’s TA Score has 5 bullish TA indicator(s).

  • BIO’s TA Score: 5 bullish, 4 bearish.
  • NVST’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIO is a better buy in the short-term than NVST.

Price Growth

BIO (@Medical Specialties) experienced а -7.04% price change this week, while NVST (@Medical Specialties) price change was +6.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was -2.69%.

Reported Earning Dates

BIO is expected to report earnings on Feb 13, 2025.

NVST is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($9.79B) has a higher market cap than NVST($3.67B). NVST has higher P/E ratio than BIO: NVST (21.74) vs BIO (3.64). BIO YTD gains are higher at: 0.833 vs. NVST (-15.337). NVST has higher annual earnings (EBITDA): 171M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. NVST (940M). BIO has less debt than NVST: BIO (1.41B) vs NVST (1.65B). BIO (2.67B) and NVST (2.57B) have equivalent revenues.
BIONVSTBIO / NVST
Capitalization9.79B3.67B267%
EBITDA-654.76M171M-383%
Gain YTD0.833-15.337-5%
P/E Ratio3.6421.7417%
Revenue2.67B2.57B104%
Total Cash1.61B940M171%
Total Debt1.41B1.65B85%
FUNDAMENTALS RATINGS
BIO: Fundamental Ratings
BIO
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIONVST
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 8 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
View a ticker or compare two or three
Ad is loading...
BIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IVOV101.771.71
+1.71%
Vanguard S&P Mid-Cap 400 Value ETF
EMXF38.720.05
+0.13%
iShares ESG Advanced MSCI EM ETF
BILZ101.110.02
+0.01%
PIMCO Ultra Short Government Active ETF
SHY82.02-0.02
-0.02%
iShares 1-3 Year Treasury Bond ETF
RHCB45.81-0.22
-0.48%
BNY Mellon Responsible Hrzns Corp Bd ETF

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with ALGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+0.54%
ALGN - NVST
52%
Loosely correlated
+0.58%
FLGT - NVST
47%
Loosely correlated
+1.65%
XRAY - NVST
42%
Loosely correlated
-1.91%
VREX - NVST
42%
Loosely correlated
+5.91%
BIO - NVST
41%
Loosely correlated
+0.94%
More